This episod of OncoDaily, hosted by Dr. Elen Baloyan, explores a groundbreaking discussion on the future of cancer treatment, cancer vaccines and their potential to transform modern oncology. In this interview, leading experts in the feild, Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, and Kristen Dahlgren, Founder of the Cancer Vaccine Coalition (CVC), share their insights into a new strategic partnership aimed at accelerating the development and accessibility of cancer vaccines.
The conversation highlights how therapeutic cancer vaccines could revolutionize oncology by not only treating cancer but also preventing recurrence.
The speakers discuss key challenges in translating scientific discoveries into clinical practice, including research silos, funding limitations, and regulatory barriers.
They also emphasize the importance of collaboration, innovation, and urgency in bringing these life-changing technologies to patients faster.